Podcast Episodes
Back to SearchPost-vaccination COVID-19 in patients with hematologic malignancies
Season 2
All four studies included in this podcast present preliminary data with modest numbers of patients, and therefore, the findings should be interpreted…
4 years, 4 months ago
Asciminib versus bosutinib in CML; dopamine signaling and hematopoietic stem cells; complement factor C5 and VTE risk
Season 2
In this week’s episode, we’ll learn more about the efficacy of asciminib in patients with chronic myeloid leukemia who are resistant or intolerant to…
4 years, 4 months ago
Danicopan add-on therapy in PNH, neural networks to identify bone marrow cells, and RNA editome and hematopoiesis
Season 2
In this week’s episode, we’ll review results of a phase 2 study showing the beneficial effects of a first-in-class factor D inhibitor as add-on thera…
4 years, 4 months ago
Machine learning in classification of AML, aging bone marrow in leukemia, and treating bleeding disorders of unknown cause
Season 2
In this week’s episode, we’ll learn more about the application of machine learning in molecular subclassification and prognostication of acute myeloi…
4 years, 4 months ago
Anti-CD36-antibody therapy of neonatal alloimmune thrombocytopenia, costs of hemophilia B gene therapy, and insights into erythroid maturation
Season 2
In this week’s episode, we’ll review a research article showing beneficial effects of prenatal immunotherapy in a mouse model of anti-CD36-mediated f…
4 years, 5 months ago
Genetic risks for CMV after BMT, multiplex gene editing to reactivate HbF, and rewiring plasma cells in light chain amyloidosis and myeloma
Season 2
In this week’s episode, we’ll discuss an analysis of genetic risks for CMV infection after an allogeneic hematopoietic stem cell transplant, learn mo…
4 years, 5 months ago
Omidubicel vs standard umbilical cord blood transplant, CAR T-cell associated lymphomas, and CD63 and ferritin export
Season 2
In this week’s episode, we’ll review results of a phase 3 randomized study demonstrating shorter time to neutrophil and platelet recovery with an ex …
4 years, 5 months ago
Iron homeostasis and anemia of inflammation in TB, and long-term outcomes of gene therapy in adenosine deaminase-deficient SCID patients
Season 2
In this week’s episode, we will review a study that prospectively followed tuberculosis patients after treatment initiation to evaluate iron handling…
4 years, 5 months ago
Immune megakaryocytes, PD1 deletions in CTCL, and COVID-19 vaccine and VITT
Season 2
In this week’s episode, we’ll review a study providing new insights on megakaryocyte diversity and function, including a unique subpopulation that ma…
4 years, 6 months ago
Inhibition of P-selectin as an anticoagulant, prognostic implications of CEBPA mutations in AML, and treating sickle cell disease with voxelitor
Season 2
In this week’s episode, we’ll review a study that demonstrates the efficacy of a synthetic inhibitor termed P-G6 that blocks P-selectin signaling and…
4 years, 6 months ago